Understanding the SCLC Drug Development Pathway: State of the Art...

adicionou um novo artigo Health

2025-08-14 07:46:27

Understanding the SCLC Drug Development Pathway: State of the Art and Beyond

Small Cell Lung Cancer continues to challenge oncologists worldwide as one of the most aggressive and treatment-resistant malignancies. Despite demonstrating initial responsiveness to conventional chemotherapy and radiation protocols, patients inevitably experience disease recurrence, leading to survival rates considerably lower than other lung cancer types. This daunting clinical...

0 Comentários 0 Compartilhamentos 213 Visualizações 0 Anterior